11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
about
18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Remyelination Therapy in Multiple SclerosisPredictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [CorrectedPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesDementia: timely diagnosis and early interventionDiagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisA correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.The feasibility of (11)C-PIB-PET/CT for amyloid plaque burden: validation of the effectiveness of CT-based partial volume correction.Amyloid Imaging: Poised for Integration into Medical Practice.Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease.Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning.Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.Imaging Alzheimer's disease pathophysiology with PET.Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.Is late-onset Alzheimer's disease really a disease of midlife?A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies.An Algorithm for Preclinical Diagnosis of Alzheimer's Disease.Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.
P2860
Q26472008-6A6EDD07-D6B8-485F-95DD-B6BD5D5F2513Q26772359-5596F738-923B-4D53-958C-947784CB2605Q27007436-C98C607C-73A4-408A-BD6D-1792CD27F3F2Q28078621-BA93A7BC-2C54-48D7-B3CE-E4AFF0DFBA63Q28082444-67097766-F374-4F96-BA79-5E8EF47602E7Q28088506-61185E86-939C-463E-AF12-6DCCB69F500EQ36209423-EC5E295D-FFD1-40F2-9B9E-FDFDA29B95EDQ37300264-F66FF384-5FB0-4579-A4AF-68D20F10F608Q37339778-17605EF9-FABB-4648-8981-9DE47BDC6A9EQ38939875-D6F43A8D-32D5-43D2-A588-2298F2998039Q39219904-F00F3EEA-D916-4205-B992-36F50F4E47E7Q46133238-189FB850-27C9-4978-81D4-8C32F9EB30ECQ46656646-5B8EF9AB-0016-4808-ADDC-974DB7D6654FQ46678949-E5B73C00-3575-4126-8B62-351A4C12930EQ47200597-1D77789C-E080-4F59-9216-7BFE8946B4CCQ47209544-913059FB-6D81-4D22-A66C-474C89C2336CQ47209556-ABCA0D76-C7D1-44A3-A51A-6E84BE258AEEQ47209563-509347BF-21A6-4514-B805-0538B013B1E6Q47555784-920AEF0E-66F5-4DA4-AF01-EC93E5281E96Q47697345-5D9F14B2-4468-4A62-912B-0F3F2EEC8833Q50044294-D6EB2AE9-08DB-4F19-BB14-095724F26698Q52340254-B8FE827A-1DA0-4807-8D6A-6405C4A42E16Q53396334-A449AE70-512C-4249-9355-C554C89CCF2EQ54943031-1FB1738B-566B-44C3-91A5-E02555399570Q54980020-D7541A45-9612-40B0-9E83-3E6675F6BB74Q55025120-7205469D-D2B7-4E62-BF81-764D4C94B3C1Q55146345-B478C554-5FC1-4D26-80E5-54EFD5B0A70DQ55398477-00B05AF9-BCEB-4832-AD37-708D26EB41E1
P2860
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@ast
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@nl
type
label
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@ast
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@nl
prefLabel
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@ast
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@en-gb
11 C-PIB-PET for the early dia ...... ild cognitive impairment (MCI)
@nl
P2093
P2860
P3181
P1476
(11)C-PIB-PET for the early di ...... ild cognitive impairment (MCI)
@en
P2093
Anna H Noel-Storr
Chris Hyde
Nadja Smailagic
Rupert McShane
Shuo Zhang
P2860
P304
P3181
P356
10.1002/14651858.CD010386.PUB2
P577
2014-07-23T00:00:00Z